Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 29:10:24.
doi: 10.1186/1550-2783-10-24. eCollection 2013.

Ubiquinol supplementation enhances peak power production in trained athletes: a double-blind, placebo controlled study

Affiliations

Ubiquinol supplementation enhances peak power production in trained athletes: a double-blind, placebo controlled study

Dietmar Alf et al. J Int Soc Sports Nutr. .

Abstract

Background: To investigate the effect of Ubiquinol supplementation on physical performance measured as maximum power output in young and healthy elite trained athletes.

Methods: In this double-blind, placebo-controlled study, 100 young German well trained athletes (53 male, 47 female, age 19.9 ± 2.3 years) received either 300 mg Ubiquinol or placebo for 6 weeks. Athletes had to perform a maximum power output test and the performance in W/kg of bodyweight was measured at the 4 mmol lactate threshold on a cycling ergometer before the supplementation treatment (T1), after 3 weeks (T2) and after 6 weeks (T3) of treatment. In these 6 weeks all athletes trained individually in preparation for the Olympic Games in London 2012. The maximum power output was measured in Watt/kilogram body weight (W/kg bw).

Results: Both groups, placebo and Ubiquinol, significantly increased their physical performance measured as maximum power output over the treatment period from T1 to T3. The placebo group increased from 3.64 ± 0.49 W/kg bw to 3.94 ± 0.47 W/kg bw which is an increase of +0.30 ± 0.18 W/kg bw or +8.5% (±5.7). The Ubiquinol group increased performance levels from 3.70 W/kg bw (±0.56) to 4.08 W/kg bw (±0.48) from time point T1 to T3 which is an increase of +0.38 ± 0.22 W/kg bw or +11.0% (±8.2). The absolute difference in the enhancement of the physical performance between the placebo and the Ubiquinol group of +0.08 W/kg bodyweight was significant (p < 0.03).

Conclusions: This study demonstrates that daily supplementation of 300 mg Ubiquinol for 6 weeks significantly enhanced physical performance measured as maximum power output by +0.08 W/kg bw (+2.5%) versus placebo in young healthy trained German Olympic athletes. While adherence to a training regimen itself resulted in an improvement in peak power output, as observed by improvement in placebo, the effect of Ubiquinol supplementation significantly enhanced peak power production in comparison to placebo.

Keywords: Elite athletes; Peak power output; Performance; Reduced CoQ10; Ubiquinol.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Individual physical fitness by time point and study group. Individual performance output measured in W/kg bw at time points T1, T2 and T3, stratified by placebo group (Control group) and Ubiquinol group (Experimental group).
Figure 2
Figure 2
Mean Measured fitness by time point and study group. Progress of fitness (absolute values in W/kg bw and percentage values) at time points T1, T2 and T3 plotted as means and one standard deviation, stratified by study group.

Similar articles

Cited by

References

    1. Diaz-Castro J, Guisado R, Kajarabille N, Garcia C, Guisado IM, de Teresa C, Ochoa JJ. Coenzyme Q(10) supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise. Eur J Nutr. 2012 Oct;51(7):791–9. doi: 10.1007/s00394-011-0257-5. Epub 2011 Oct 12. - DOI - PubMed
    1. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A. 1991;88:1646–1650. doi: 10.1073/pnas.88.5.1646. - DOI - PMC - PubMed
    1. Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007;47:19–28. doi: 10.1016/j.yrtph.2006.07.001. - DOI - PubMed
    1. Ikematsu H, Nakamura K, Harashima S, Fujii K, Fukutomi N. Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial. Regul Toxicol Pharmacol. 2006;44:212–218. doi: 10.1016/j.yrtph.2005.12.002. - DOI - PubMed
    1. Langsjoen PH, Langsjoen AM. Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors. 2008;32:119–128. doi: 10.1002/biof.5520320114. - DOI - PubMed

LinkOut - more resources

-